Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Engineering probes and cancer therapeutics from epigenetic reader libraries Engineering probes and cancer therapeutics from epigenetic reader libraries

FY 2018-19

Summary
Epigenetics is an emerging field in science that focuses on the regulation of DNA through modifications of DNA binding proteins. These modifications, or epigenetic markers, are added to DNA binding proteins by proteins called “epigenetic writers”. Depending on the marker added, different changes to local DNA accessibility can result causing alterations to gene expression via gene silencing or gene activation. “Epigenetic readers” also play an important role in gene expression. They act like interpreters and translate specific epigenetic modifications into changes in cellular processes such as DNA repair and replication. The study of epigenetic modifications is important because a wide range of cancers (e.g. lymphoma and pancreatic cancer) can be caused by misregulation of epigenetic writers and readers. Although links between epigenetics and cancer are becoming more evident, the specific mechanisms behind these processes remain largely undiscovered. And thus, the rationale to study the role of epigenetic modifications in cancers has only grown. Unfortunately, the scarcity of molecular probes has become a roadblock for those studying epigenetics and the specific mechanisms that cause epigenetically-linked cancers. Through my research, I aim to create libraries containing billions of protein variants engineered from epigenetic readers that are already known to bind to specific epigenetic markers involved in lymphoma and pancreatic cancer. These libraries will be subsequently screened for protein variants that bind both more tightly and precisely to their target epigenetic markers. Finally, these proteins will be tested as novel probes to compare epigenetic markers between healthy and cancer cells and further engineered into novel cancer therapeutics.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
411300
Name
Tang Qichen
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Engineering probes and cancer therapeutics from epigenetic reader libraries Engineering probes and cancer therapeutics from epigenetic reader libraries
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Acetylation; Cancer; Epigenetics; Histones; Methylation; Phage Display; Post-Translational Modifications; Probe; Protein Engineering; Protein Library
Abstract
Epigenetics is an emerging field in science that focuses on the regulation of DNA through modifications of DNA binding proteins. These modifications, or epigenetic markers, are added to DNA binding proteins by proteins called “epigenetic writers”. Depending on the marker added, different changes to local DNA accessibility can result causing alterations to gene expression via gene silencing or gene activation. “Epigenetic readers” also play an important role in gene expression. They act like interpreters and translate specific epigenetic modifications into changes in cellular processes such as DNA repair and replication. The study of epigenetic modifications is important because a wide range of cancers (e.g. lymphoma and pancreatic cancer) can be caused by misregulation of epigenetic writers and readers. Although links between epigenetics and cancer are becoming more evident, the specific mechanisms behind these processes remain largely undiscovered. And thus, the rationale to study the role of epigenetic modifications in cancers has only grown. Unfortunately, the scarcity of molecular probes has become a roadblock for those studying epigenetics and the specific mechanisms that cause epigenetically-linked cancers. Through my research, I aim to create libraries containing billions of protein variants engineered from epigenetic readers that are already known to bind to specific epigenetic markers involved in lymphoma and pancreatic cancer. These libraries will be subsequently screened for protein variants that bind both more tightly and precisely to their target epigenetic markers. Finally, these proteins will be tested as novel probes to compare epigenetic markers between healthy and cancer cells and further engineered into novel cancer therapeutics.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tang, Qichen
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~